These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3188011)

  • 1. Diminished regulation of mesolimbic dopaminergic activity in rat after chronic inorganic lead exposure.
    Lasley SM; Lane JD
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):474-83. PubMed ID: 3188011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of dopaminergic activity, but not tyrosine hydroxylase, is diminished after chronic inorganic lead exposure.
    Lasley SM
    Neurotoxicology; 1992; 13(3):625-35. PubMed ID: 1361980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC; Moore KE; Demarest KT
    J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
    Kilts CD; Anderson CM; Ely TD; Nishita JK
    J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP; Wolf ME; Roth RH
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE; Haubrich DR; Williams M
    Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered central monoamine response to D-amphetamine in rats chronically exposed to inorganic lead.
    Lasley SM; Greenland RD; Minnema DJ; Michaelson IA
    Neurochem Res; 1985 Jul; 10(7):933-44. PubMed ID: 2413381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity.
    Widzowski DV; Finkelstein JN; Pokora MJ; Cory-Slechta DA
    Neurotoxicology; 1994; 15(4):853-65. PubMed ID: 7715856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal lead exposure produces long-term enhancement of dopaminergic reactivity in rat offspring.
    Szczerbak G; Nowak P; Kostrzewa RM; Brus R
    Neurochem Res; 2007 Oct; 32(10):1791-8. PubMed ID: 17404837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
    Pokora MJ; Richfield EK; Cory-Slechta DA
    J Neurochem; 1996 Oct; 67(4):1540-50. PubMed ID: 8858938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
    Cory-Slechta DA; O'Mara DJ; Brockel BJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):794-805. PubMed ID: 9694936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postnatal inorganic lead exposure decreases the number of spontaneously active midbrain dopamine neurons in the rat.
    Tavakoli-Nezhad M; Barron AJ; Pitts DK
    Neurotoxicology; 2001 Apr; 22(2):259-69. PubMed ID: 11405257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
    Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
    J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Region-specific alterations in dopamine and serotonin metabolism in brains of rats exposed to low levels of lead.
    Kala SV; Jadhav AL
    Neurotoxicology; 1995; 16(2):297-308. PubMed ID: 7566689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC; de Vries JB; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):304-11. PubMed ID: 6514014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead.
    Lasley SM; Gilbert ME
    Brain Res; 1996 Oct; 736(1-2):125-34. PubMed ID: 8930317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.